Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06711952 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 29, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Mar 31, 2025 to Aug 31, 2025
    • Site contact updated
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.
Trial Details
NCT Number NCT06711952
Lead Sponsor Ludwig-Maximilians - University of Munich
Collaborators: Medotrax UG
Conditions
(from sponsor)		 Alzheimer Disease, Subjective Cognitive Decline
Related terms Alzheimer Disease
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov